Won-Ki Cho
Chairman bei CHOA PHARMACEUTICAL CO., LTD.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Won-Ki Cho is currently the Chairman of ChoA Pharmaceutical Co., Ltd.
and Medipharm.
He has an undergraduate degree from Pusan National University and Kyungpook National University, and a doctorate degree from Pukyong National University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2023 | 3 464 843 ( 11,18% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Won-Ki Cho
| Unternehmen | Position | Beginn |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Chairman | 01.01.1988 |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Chairman | - |
Ausbildung von Won-Ki Cho
| Pusan National University | Undergraduate Degree |
| Kyungpook National University | Undergraduate Degree |
| Pukyong National University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
